ClinicalTrials.gg
CompletedNCT02310633DPSVMUpdated Nov 1, 2024

Developing Process-Specific Verbal Memory Interventions for Veterans With Tramatic Brain Injury (TBI)

An interventional study of Memory Strategy Training and Errorless Learning in Traumatic Brain Injury, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 25 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-01.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Randomized
Ages
25 Years to 65 Years
Sex
All
01

Study summary

Blast-related and blunt traumatic brain injury is a key priority area of Rehabilitation Research \& Development (RR\&D) and represents a critically important public health problem facing the Veteran population. Developing efficacious treatments for persistent memory deficits seen in this population is a key step in reducing the impact that such problems have in the everyday lives of Veterans. Memory problems after TBI in Veterans are quite heterogeneous, and efficacy will likely be maximized by developing and disseminating multiple alternative treatments individually matched to the Veteran's key deficits, and by research that seeks to understand the cognitive and neural basis of treatment-related change over time. The results of this approach may aid clinical decision making and assignment of patients to rehabilitative treatments most likely to improve memory capacity and functional outcome.

Read the detailed description

Memory dysfunction can result from impairments along a continuum of information processing, from poor initial acquisition of information during learning to disturbed retrieval of stored memory when it is later needed to perform a task1. The heterogeneous nature of TBI-related memory impairment is well-known, and there is a critical need to better understand such disease heterogeneity in order to enhance diagnosis and therapeutic management2. Several subtypes of memory dysfunction after TBI have been identified3,4. First, some TBI survivors exhibit impaired memory acquisition/encoding (e.g., frontal system damage)5. Second, some exhibit impaired memory consolidation/storage impairment (e.g., prominent damage to temporal lobe systems6). Third, some show impairment in retrieval of information5,7. This heterogeneity results from the variable nature and severity of underlying brain trauma resulting from unpredictable mechanical forces2,8.

It has been suggested that parsing this underlying variability should take precedence over generalities regarding the effect of TBI on memory when conceptualizing or treating memory disorders in this population8 Nevertheless, many rehabilitation programs utilize a "one size fits all" approach to memory training, based (typically) on training compensatory strategies, with no training specifically targeted to the identifiable component processes of memory that could be differentially impaired (encoding, consolidation/storage, and retrieval), and which might respond differentially to more specifically targeted treatment. This situation in clinical practice is due to the lack of evidence upon which to base informed decision-making in allocating specifically targeted memory re-training for individual survivors of TBI, based on clinical test results identifying which memory component processes are impaired (encoding, consolidation/storage, and retrieval). Because of this, there is little attempt to appropriately match patient impairment to targeted treatments.

There are existing training protocols for training these three components of memory processing, as follows: encoding (memory strategy training9), consolidation (errorless learning10), and retrieval (retrieval practice11, but their efficacy has not been tested in TBI survivors with documented impairments in each component. That is, to the investigators' knowledge, there is no solid evidence for memory training in TBI survivors that supports the widely held belief that specifically matching the patient impairment to the treatment leads to better treatment outcomes. This proposal attempts to fill this gap in the investigators' knowledge. Prior to testing the efficacy of these three types of training in a large trial, it is important to make standard preparations, such as refining and testing training materials and ensuring fidelity of treatment methods across clinicians.

Aim 1. Aim 1 is to refine and validate three separate, process-specific memory rehabilitation treatments that focus on improving information-processing at the encoding, consolidation, or retrieval stage for Veterans with chronic moderate/severe TBI.

Objective 1.1. Generate treatment manuals for three process-specific memory treatments.

Objective 1.2. Test and refine treatment fidelity so that each of the three interventions can be reliably delivered by different clinicians.

Aim 2. Aim 2 is to provide a preliminary test of the response to the three memory interventions. At baseline, TBI survivors will be evaluated for memory function in each of these three memory component processes using established neuropsychometric methods. Their experimental treatment allocation will be to the treatment targeting their most impaired memory component. In addition, each subject will serve as his/her own control, by engaging in a treatment targeted to another memory component ('mismatched' group).

Hypothesis A. Matched vs. mismatched group will show differential improvement in memory component function, with the former group benefitting to a significantly greater degree. (Primary measures: Memory component performance, encoding, consolidation, retrieval; secondary: cognitive function and quality of life).

Aim 3. Aim 3 is to establish links between the behavioral taxonomy of the three memory components and differences in brain structure and function documented with diffusion tensor imaging and functional connectivity analysis. This is a key first step in establishing brain-based metrics of neuroplastic change after memory therapy in the investigators' research program.

Objective 3.1. Identify specific and unique imaging signatures that distinguish patients with deficits in encoding, consolidation, and retrieval, respectively. Primary measures: structural measures of morphometry and white matter integrity (FA) and functional connectivity (cross correlation and total interdependence) in identified brain networks damaged in TBI.

Clinical Implications. This research has the potential to devise a method to match specific subcomponents of memory impairment to specifically targeted memory interventions, thus maximizing recovery of memory and function. The results of this investigation will be used to refine the interventions, to evaluate cognitive and functional endpoints, and to power a larger clinical trial that will yield data enabling clinicians to match TBI patients to effective treatments based on their individual profile of memory dysfunction.

02

Conditions studied

  • Traumatic Brain Injury

Keywords

  • TBI
  • memory disorder
  • injury, brain, traumatic
  • rehabilitation
03

In context

Brain Injuries, Traumatic

1,818 studies on the registry are indexed under Brain Injuries, Traumatic; 460 are open to participants now.

This study's enrollment of 8 is below the median of 55 across 1,158 interventional studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,767 studies on the registry; 394 are open to participants now.

Of its 209 completed or terminated interventional studies of FDA-regulated products, 183 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Veterans aged 25-65 who are post-deployment,
  • having served in Operation Iraqi Freedom (OIF), Operation Enduring Freedom (OEF), or Operation New Dawn (OND),
  • who meet criteria for moderate or severe TBI during deployment,
  • are eligible to participate.
  • Patients will meet the 2007 VA/DoD criteria54,

    • supplemented by data from the VA TBI Identification Semi-Structured Interview55.
  • All patients will have gone through Level I and II assessments with positive findings.
  • Primary inclusion criteria:

    • Moderate to Severe Traumatic Brain Injury (M-STBI) (blast and blunt),
    • > 6 months post-injury,
    • no receptive aphasia (impairing ability to comprehend task instructions),
    • able to participate in return visits.

Exclusion criteria

Exclusion Criteria:

  • Primary exclusion criteria:

    • No MRI contraindications,
    • not claustrophobic,
    • no current or past history of disabling Axis I psychiatric disorders (except for PTSD and depression),
    • no active substance abuse,
    • not pregnant.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
8 participants (actual)

Study arms

  • Active comparator
    Memory Strategy Training

    This arm involves intervention that teaches participants to use active encoding strategies to learn and remember new information.

    Behavioral: Memory Strategy Training

  • Active comparator
    Errorless Learning

    This arm involves intervention that enhances consolidation of correct target information by preventing false recall of incorrect information during the acquisition phase.

    Behavioral: Errorless Learning

  • Active comparator
    Retrieval Practice

    This arm involves intervention that enhances retrieval of correct target information by actively practicing retrieval in the presence of a cue.

    Behavioral: Retrieval Practice

Interventions

  • BehavioralMemory Strategy Training

    This intervention involves intervention that teaches participants to use active encoding strategies to learn and remember new information. The intervention will be implemented using verbal and face-name paired associate learning.

  • BehavioralErrorless Learning

    This intervention enhances consolidation of correct target information by preventing false recall of incorrect information during the acquisition phase. Participants are encouraged to recall target information only if they are sure it is correct, thus eliminating errors. The intervention will be implemented using verbal and face-name paired associate learning.

  • BehavioralRetrieval Practice

    This intervention enhances retrieval of correct target information by actively practicing retrieval in the presence of a cue. The intervention will be implemented using verbal and face-name paired associate learning.

06

What researchers measure

Primary outcomes

  1. Change in performance on paired-associate learning of words and face-name pairs

    Participants will be tested each session on paired-associate learning (words and face-name pairs) for trained and untrained items

    Time frame: At the end of each session (twice weekly), up to 12 weeks

  2. Change in functional brain connectivity within memory-relevant brain networks

    Participants will undergo MRI scanning before and after memory interventions to assess the effect of intervention on functional brain connectivity in default mode network (DMN), task-positive network (TPN), and salience network (SN)

    Time frame: Prior to start of intervention (Week 0) and again at the end of intervention (Week 8)

Secondary outcomes

  1. Mayo-Portland Adaptability Inventory (MPAI-4)

    This measure assesses the overall impact of TBI on functional capacity

    Time frame: Week 0, Week 8, and 1 month after treatment is concluded (Week 12)

  2. RAVLT

    This is an independent measure of list learning designed to assess the effect of memory intervention on learning of untrained items.

    Time frame: Week 0, Week 8, and 1 month after treatment is concluded (Week 12)

  3. Brief Visuo-Spatial Learning Test-Revised (BVLT-R)

    This is a measure of nonverbal memory (drawing from memory), designed to assess the effect of memory intervention on learning and memory for untrained items.

    Time frame: Week 0, Week 8, and 1 month after treatment is concluded (Week 12)

  4. Ecologically Oriented Neurorehabilitation of Memory (EON-MEM) Everyday Memory Simulations

    These are tasks of everyday memory designed to assess whether effects of memory intervention generalize to real-world memory tasks.

    Time frame: Week 0, Week 8, and 1 month after treatment is concluded (Week 12)

  5. Quality of Life after Brain Injury (QOLIBRI)

    This is a quality of life measure after brain injury, designed to assess whether effects of memory intervention extend to quality of life.

    Time frame: Week 0, Week 8, and 1 month after treatment is concluded (Week 12)

  6. PROMIS and Neuro-QOL Item Banks

    These items assess outcome from the patient perspective (patient-reported outcomes)

    Time frame: Week 0, Week 8, and 1 month after treatment is concluded (Week 12)

  7. Satisfaction with Life Scale (SWLS)

    This questionnaire assesses overall life quality and satisfaction.

    Time frame: Week 0, Week 8, and 1 month after treatment is concluded (Week 12)

07

Study locations

1 site
  • North Florida/South Georgia Veterans Health System, Gainesville, FL
    Gainesville, Florida 32608, United States
08

References and documents

Study documents

  • Study protocol · Mar 4, 2019
  • Statistical analysis plan · Jun 9, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Data will be available to other researchers in a de-identified, password protected file.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2015 to primary completion in Dec 2017, 35 months.

Of 491 non-industry interventional studies with no phase under Brain Injuries, Traumatic, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 64. This study's 35 months is close to that.

Counting every sponsor, half of 515 studies reached it within 36 months; a quarter within 21 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 19, 2014
First posted
Dec 8, 2014
StartActual
Jan 5, 2015
Primary completionActual
Dec 22, 2017
CompletionActual
Dec 29, 2017
Last update
Nov 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02310633
Responsible party
Sponsor
First posted
Dec 8, 2014
Start date
Jan 5, 2015
Primary completion
Dec 22, 2017
Completion
Dec 29, 2017
Last update
Nov 1, 2024

Study contacts

Russell M Bauer, PhD
principal investigator · North Florida/South Georgia Veterans Health System, Gainesville, FL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion